Concepedia

Aaron Mochizuki

AM

Statistics

Publications

7

Citations

2.7K

H-Index

7

Active since

2018

Affiliations

University of California, Los Angeles(Current)

Parker Institute for Cancer Immunotherapy

Stanford University

Dana-Farber Cancer Institute

Howard Hughes Medical Institute

Aaron Mochizuki is an author at University of California, Los Angeles specializing in oncology, immunology, and cancer immunotherapy.

ORCID

Publications per year

2018–2022

7

Publications

7

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla et al. · Nature Medicine · 2019 · 1.4K citations

, , +17

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom et al. · Nature · 2022 · 782 citations · Full text

, , +13

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma

Lu Sun, Aaron Mochizuki, Jeremy Reynoso et al. · Nature Communications · 2021 · 261 citations · Full text

, , +17

Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma

Erik Ladomersky, Lijie Zhai, Kristen L. Lauing et al. · Clinical Cancer Research · 2020 · 110 citations · Full text

, , +17

Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and Activation

Tom B. Davidson, Melody S. Hsu, Shaina Sedighim et al. · Clinical Cancer Research · 2018 · 100 citations

, , +15

1–5 of 7